PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33758606-6	2021	Compared with erlotinib alone, beta-elemene plus erlotinib significantly promoted the apoptosis of NCI-H1975 cells, accompanied by the down-regulated expression of P-mTOR, P-EGFR, CHOP proteins and up-regulated expression of P-AMPKalpha and Bax proteins.	beta-elemene	31-43	epidermal growth factor receptor	Homo sapiens	174-178	
31343107-6	2019	Further analysis revealed that beta-elemene suppressed aerobic glycolysis by blocking PKM2 nuclear translocation and the expression of EGFR, GLUT1 and LDHA by influencing the expression of importin alpha5.	beta-elemene	31-43	epidermal growth factor receptor	Homo sapiens	135-139	
32199253-0	2020	beta-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.	beta-elemene	0-12	epidermal growth factor receptor	Homo sapiens	104-108	
32199253-12	2020	Further studies showed that beta-Elemene upregulated Cbl-b expression, resulting in inhibition of the EGFR-ERK/AKT pathways, which regulate MMP-2/9.	beta-elemene	28-40	epidermal growth factor receptor	Homo sapiens	102-106	
32199253-15	2020	CONCLUSION: Our results suggested that beta-Elemene inhibits the metastasis of MDR gastric cancer cells by modulating the miR-1323/Cbl-b/EGFR signaling axis.	beta-elemene	39-51	epidermal growth factor receptor	Homo sapiens	137-141	
27498706-0	2016	beta-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.	beta-elemene	0-12	epidermal growth factor receptor	Homo sapiens	111-115	
27498706-6	2016	The combination medication of beta-elemene and gefitinib not only inhibited the survival and proliferation of glioblastoma multiforme cells via inhibition of EGFR signaling pathway but also induced more distinct apoptosis and autophagy in the glioblastoma multiforme cells than the gefitinib monotherapy.	beta-elemene	30-42	epidermal growth factor receptor	Homo sapiens	158-162	
27498706-7	2016	These results showed that beta-elemene might be one potential adjuvant to enhance the effect of EGFR inhibitor and reduce the resistance of gefitinib in glioblastoma multiforme.	beta-elemene	26-38	epidermal growth factor receptor	Homo sapiens	96-100